Protara Therapeutics 주식 (NASDAQ: TARA)

에 대한 최신 뉴스 Protara Therapeutics (NASDAQ:TARA) 주식

Protara Therapeutics

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

$BTC

MARA

MSTR

ORCL

ROKU

SOUN

TARA

매주, 벤징가의 스톡 위스퍼 지수(Benzinga&#39;s Stock Whisper Index)는 독점 데이터(proprietary data)와 패턴 인식의 조합을 사용하여 표면 바로 아래에서 주목을 받을 만한 주식 5종목을 소개한다.

벤징가의 &#39;스톡 위스퍼&#39; 지수: 프로타라, 마라, 트레이드 데스크, 사운드하운드 AI 및 오라클

Biotech

Health Care

Exclusives

Tech

Trading Ideas

매주, 벤징가의 스톡 위스퍼 지수(Benzinga&#39;s Stock Whisper Index)는 독점 데이터(proprietary data)와 패턴 인식의 조합을 사용하여 표면 바로 아래에서 주목을 받을 만한 주식 5종목을 소개한다. 투자자들은 가치가 저평가된, 관심이 적은, 새로운 주식들을 항상 찾고 있다. 소매 거래자들이 사용할 수 있는 방법은 무수히 많기 때문에 새로운 기회를 발견하고 특정 주식이 관심을 가져야 하는 이유를 이해하기 위해 풍부한 정보를 조사하는 것이 어려운 경우가 많다.

Protara Therapeutics, Inc. - Common Stock

Protara Therapeutics Inc

Taraxa

Tarachi Gold Corp

TARANIS RESOURCES INC ORD by Taranis Resources Inc.

Taranis Resources Inc

UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) has outperformed the market over the past 15 years by 8.74% on an annualized basis producing an average annual return of 20.51%. Currently, UnitedHealth Group has a market capitalization of $500.10 billion. 
Buying $1000 In UNH: If an investor had bought $1000 of UNH stock 15 years ago, it would be worth $15,728.51 today based on a price of $543.42 for UNH at the time of writing.
<h3>UnitedHealth Group's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736984708_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Here's How Much You Would Have Made Owning UnitedHealth Group Stock In The Last 15 Years

President-elect Donald Trump is considering issuing an executive order aimed at rescuing TikTok from being banned from U.S. app<a href="https://www.benzinga.com/25/01/42931704/tiktok-users-call-on-trump-to-deliver-immediately-on-his-promise-to-save-app-from-us-ban-we-dont-need-the-supreme-court-to"> stores in four days.&nbsp;</a>
What To Know: According to the Washington Post, sources familiar with the matter said Trump is brainstorming strategies to save TikTok from the law signed by President Joe Biden set to ban the app on Sunday. 
Read Next: <a href="https://www.benzinga.com/news/legal/25/01/42979220/biden-announces-more-student-loan-forgiveness-bringing-debt-relief-to-nearly-5-million-borrowers">Biden Announces More Student Loan Forgiveness, Bringing Debt Relief To Nearly 5 Million Borrowers</a>
One of the strategies Trump is considering is an executive order that would suspend enforcement of the law for 60 to 90 days. One source said the president-elect would like to be seen "making a deal" to save the popular social media app. 
It is not clear whether an executive order would keep TikTok in U.S. app stores, overriding a law passed by Congress.&nbsp;
"TikTok will still be banned, and it will still be illegal for Apple and Google to do business with them. But it will make the president's intention not to enforce the law that much more official," Alan Rozenshtein, a former national security adviser to the Justice Department, told the Washington Post.&nbsp;
What Else: A Bloomberg report on Monday suggested that Elon Musk is in talks with Chinese officials regarding a potential scenario where Musk's X platform <a href="https://www.benzinga.com/general/social-media/25/01/42965533/elon-musk-emerges-as-potential-tiktok-us-buyer-as-ban-deadline-looms-company-terms-it-pure-fiction">could take over </a>TikTok's U.S. operations.&nbsp;
However, a TikTok spokesperson denied the report telling Benzinga, "We can't be expected to comment on pure fiction."
Other interested parties include Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) and Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), as well as a consortium led by the "Shark Tank" investor Kevin O'Leary.
If no deal is reached by the deadline, TikTok <a href="https://www.benzinga.com/general/social-media/25/01/42957741/tiktok-ban-deadline-ahead-what-will-happen-to-app-on-your-phone">will be banned</a> from app stores in the U.S. on Sunday, Jan. 19. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42919029/supreme-court-hears-tiktok-oral-arguments">Supreme Court Hears TikTok Arguments With App&#8217;s Ban Ahead: &#8216;Essentially, The Platform Shuts Down&#8217;&nbsp;</a></li>
</ul>
Photo: Shutterstock

Government

Social Media

Politics

Legal

General

MSFT

Trump Considers Executive Order To 'Save' TikTok From Being Banned In 4 Days

Silicon Valley billionaires are poised to join forces with protectionist hard-liners in Trump&#8217;s second term, marking an alliance that could fundamentally reshape American economic policy.
The incoming administration&#8217;s economic team is a mix of competing interests, including tech industry power brokers and America-first ideologues, creating what The Economist describes as the largest and most diverse group of economic advisers in presidential history.&nbsp;
At its center is Elon Musk, whose new role leading a government efficiency drive signals Trump&#8217;s embrace of tech industry disruption within the federal bureaucracy.
Don't Miss:
<ul>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
</ul>
Commerce Secretary nominee Howard Lutnick underscores the administration's protectionist tilt, saying before the election, &#8220;You&#8217;ve got to tariff the rest of the world. Keep them the heck out. Bring the manufacturing back here.&#8221; Even traditionally moderate nominees like Treasury pick Scott Bessent and National Economic Council leader Kevin Hassett have endorsed aggressive tariff policies.
The <a href="https://www.benzinga.com/news/24/11/41965420/elon-musk-vivek-ramaswamy-led-department-of-government-efficiency-opens-account-on-x-says-it-is-working-overtime">newly created Department of Government Efficiency (DOGE)</a>, coled by Musk and former presidential candidate Vivek Ramaswamy, could be a direct channel between Silicon Valley and the White House. North Carolina Rep. Dan Bishop told The Economist that the DOGE development marks a &#8220;fundamental change in the dynamic&#8221; of government operations.
Silicon Valley&#8217;s influence extends throughout the administration. Venture capital giant <a href="https://www.benzinga.com/24/11/42253427/elon-musks-doge-dream-team-from-marc-andreessen-to-ubers-travis-kalanick-silicon-valley-titans-join-forces-to-overhaul-federal-spending">Marc Andreessen has spent time at Mar-a-Lago</a> shaping tech policy and personnel decisions. His firm Andreessen Horowitz has placed several partners in key positions, including Scott Kupor as director of the Office of Personnel Management.
See Also: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a>
Stephen Miller, appointed deputy chief of staff, will spearhead the America First agenda from within the White House. Miller&#8217;s influence extends beyond immigration policy to broader economic strategy, including a planned two-phase approach beginning with immigration reform and later tackling tax legislation.
Budget director nominee Russ Vought, whom Miller praised as &#8220;the guy for the last four years that has been developing the plan to take down the deep state,&#8221; arrives with a blueprint for restructuring federal agencies. Trade policy remains a central battleground. While Peter Navarro returns as a presidential adviser advocating extensive tariffs, incoming trade representative Jamieson Greer has called for revoking China&#8217;s normal trading status. The administration&#8217;s push for economic decoupling from China creates tension with business interests, including Musk&#8217;s Tesla operations in the country.
Trending: With 100+ historic trademarks including some of the high grossing characters in history, like Cinderella, Snow White and Peter Pan, <a href="https://www.benzinga.com/money/elf-labs-1">this company is transforming the $2 trillion entertainment market with patented AR, VR, and AI tech. — For a short window, investors are able to claim $2/share ($980 min).</a>
Internal conflicts loom between the administration&#8217;s competing factions. Tech leaders advocate for expanded skilled immigration through H-1B visas, while Miller&#8217;s wing pushes for broad restrictions. Even on core Republican principles like tax cuts, divisions have emerged, with former strategist Steve Bannon calling for increased corporate taxation.
The appointment of Miller&#8217;s wife Katie to the efficiency department suggests the America First camp seeks to maintain oversight of the tech contingent&#8217;s reform agenda. Early political challenges, including recent congressional budget negotiations, have already tested the limits of this coalition&#8217;s influence.
As the administration prepares to take office, the alliance of Silicon Valley disrupters, economic nationalists and traditional conservatives must translate campaign promises into coherent policy.&nbsp;
Their success or failure could determine the future of American economic policy for years to come.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/advisor-adv-warren-buffett">Warren Buffett Flipped His Neighbor's $67,000 Life Savings Into A $50 Million Fortune — This Would Be Worth Over $500 Million Today</a></li>
<li><a href="https://www.benzinga.com/money/suze-orman-retirement-bucket">&#8216;Which Bucket Do I Draw From First?&#8217; Suze Orman Explains To 67-Year-Old The Best Order For Tapping Into Her Retirement Accounts</a></li>
</ul>

Startups

Elon Musk's Role In Shaping Trumponomics: 'You've Got To Tariff The Rest Of The World'

Media company Warner Bros. Discovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) could be in for a tough fourth quarter with concerns about the company's DC Studios reboot, the loss of NBA rights and the underperformance of "Joker: Folie a Deux" <a href="https://www.benzinga.com/general/entertainment/24/10/41210999/joker-2-stumbles-at-box-office-no-laughing-matter-for-warner-bros-stock">at the box office.</a>
These are among the main reasons an analyst is lowering estimates and the price target on Warner Bros. Discovery ahead of fourth-quarter financial results.
The WBD Analyst: Goldman Sachs analyst Michael Ng maintained a Neutral rating on Warner Bros. Discovery and lowered the price target from $10.75 to $9.75.
Read Also: <a href="https://www.benzinga.com/24/12/42603589/disney-hits-2-billion-domestic-box-office-wins-top-honors-global-box-office-2025-to-grow-8-to-33b-analyst-says">Disney Hits $2 Billion Domestic Box Office, Earns Top Honors</a>
The Analyst Takeaways: The analyst expects Warner Bros. to report strong direct-to-consumer additions in the fourth quarter.
Outside of that segment, Ng sees struggles for the media company in other segments including linear networks, advertising and studio. &nbsp;
"WBD stock has outperformed the market since its last earnings report on 11/7/24 during which WBD reached a new agreement with NBA, had an earlier than-expected carriage renewal with Comcast, and announced a new corporate structure plan that splits linear networks business from streaming and studios," Ng said.
The analyst said investor debates will center on topics such as the linear networks outlook, direct-to-consumer momentum and the DC Studios reboot moving forward.
For the DC Studios segment, the analyst lowers the EBITDA target from $874 million to $800 million, citing the underperformance of "Joker: Folie a Duex" at the box office.
While there are concerns about the impact from the flop of "Joker: Folie a Deux" and the <a href="https://www.benzinga.com/general/sports/24/11/42075473/warner-bros-discovery-nba-deal-best-case-scenario-analyst-says-renewal-structure-could-boost-annual-profit">loss of NBA rights,</a> the analyst sees strength ahead for the DTC segment.
"Looking ahead, we estimate WBD can achieve $1.56 bn in DTC EBITDA in 2025E driven by international market launches and content timing."
The analyst highlights international expansion opportunities for the Max streaming platform, password-sharing initiatives, new content, price increases, bundling and ad-lite penetration as catalysts to help power streaming growth.
"Although we're encouraged by WBD's DTC momentum as well as investments in Linear Networks sports programming, the loss of domestic NBA media rights creates mid-term uncertainty in the outlook for Linear Networks profitability," Ng said.
WBD Price Action: Warner Bros. Discovery stock closed Wednesday up .62% to $9.79 versus a 52-week trading range of $6.64 to $12.70. Warner Bros. stock is down 5% over the last year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/12/42750888/top-anticipated-2025-movies-for-big-screen-success-and-stocks-investors-should-watch">Top Anticipated 2025 Movies For Big Screen Success And Stocks Investors Should Watch</a></li>
</ul>
Photo: Courtesy Warner Bros. Discovery

Analyst Color

Entertainment

Price Target

Reiteration

Analyst Ratings

Media

Warner Bros. Discovery Analyst Says DTC Strength Won't Offset 'Joker: Folie A Deux' Flop, NBA Rights Concerns

Moodys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCO#NYSE">MCO</a>) has outperformed the market over the past 10 years by 6.11% on an annualized basis producing an average annual return of 17.47%. Currently, Moodys has a market capitalization of $85.42 billion. 
Buying $100 In MCO: If an investor had bought $100 of MCO stock 10 years ago, it would be worth $500.48 today based on a price of $471.35 for MCO at the time of writing.
<h3>Moodys's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736982908_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today

The U.S. Department of Transportation and Department of Justice jointly filed a lawsuit on Wednesday against Southwest Airlines Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) for operating "chronically delayed flights" that caused <a href="https://www.benzinga.com/general/travel/25/01/42791291/jetblue-fined-2-million-for-chronic-flight-delays-delta-united-rank-among-most-on-time-airlines">disruptions to passengers. </a>
The Details: DOT said its investigation found Southwest operated two chronically delayed flights, resulting in 180 flight disruptions for passengers between April and August 2022. DOT rules define a chronically delayed flight as one that is flown at least 10 times a month and arrives more than 30 minutes late more than 50% of the time. 
Read Next: <a href="https://www.benzinga.com/news/legal/25/01/42979220/biden-announces-more-student-loan-forgiveness-bringing-debt-relief-to-nearly-5-million-borrowers">Biden Announces More Student Loan Forgiveness, Bringing Debt Relief To Nearly 5 Million Borrowers</a>
"As part of our commitment to supporting passenger rights and fairness in the market for airline travel, we are suing Southwest Airlines for disrupting passengers' travel with unlawful chronic flight delays," Transportation Secretary Pete Buttigieg said in a statement.&nbsp;
"Airlines have a legal obligation to ensure that their flight schedules provide travelers with realistic departure and arrival times. Today&#8217;s action sends a message to all airlines that the Department is prepared to go to court in order to enforce passenger protections," Buttigieg added.&nbsp;
Southwest responded with a statement that it was "disappointed that DOT chose to file a lawsuit over two flights that occurred more than two years ago."
"Any claim that these two flights represent an unrealistic schedule is simply not credible when compared with our performance over the past 15 years," Southwest said.
The lawsuit against Southwest comes only 12 days after the DOT fined JetBlue Airways Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) $2 million for chronic flight delays, which marked the <a href="https://www.transportation.gov/briefing-room/dot-penalizes-jetblue-chronic-flight-delays">first time</a> an airline had been fined for chronic flight delays. 
LUV Price Action: According to Benzinga Pro, Southwest Airlines shares are trading flat after-hours on Wednesday at $32.83.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/travel/25/01/42992007/trump-cabinet-confirmation-hearings-on-wednesday-departments-of-transportation-energy-state-attorney-general-cia-director">Trump Cabinet Confirmation Hearings On Wednesday: Departments Of Transportation, Energy, State; Attorney General, CIA Director</a>&nbsp;</li>
</ul>
Photo: Shutterstock

Regulations

Travel

After-Hours Center

JBLU

Southwest Airlines Is Sued By Department Of Transportation Over 'Chronically Delayed' Flights

Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) has outperformed the market over the past 10 years by 9.7% on an annualized basis producing an average annual return of 21.06%. Currently, Boston Scientific has a market capitalization of $142.86 billion. 
Buying $1000 In BSX: If an investor had bought $1000 of BSX stock 10 years ago, it would be worth $6,761.34 today based on a price of $97.01 for BSX at the time of writing.
<h3>Boston Scientific's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736982008_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

Oil prices surged on Wednesday, with West Texas Intermediate light crude rising about 4% to above $80 per barrel for the first time <a href="https://www.benzinga.com/markets/commodities">since mid-July 2024. </a>
This rally comes against a backdrop of intensifying concerns over global supply disruptions and the announcement of a <a href="https://www.benzinga.com/news/global/25/01/43017362/israel-hamas-agree-to-ceasefire-deal-including-hostage-release-biden-confirms">ceasefire in Gaza</a> after a devastating 15-month war.
Crude prices — as tracked by the United States Oil Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>) — haven&#8217;t seen a single-day surge of this magnitude since early October 2024.
<h1 class="wp-block-heading">What's Driving Oil Higher?</h1>
Despite positive geopolitical developments in the Middle East with the ceasefire between Israel and Hamas, traders remain focused on tightening supply fundamentals.
According to Reuters, the ceasefire agreement, brokered by U.S., Egyptian and Qatari diplomats, outlines an Israeli military withdrawal from Gaza and a prisoner exchange.
While this marks a significant step toward de-escalation in the Middle East, oil markets seem more concerned with a series of factors that could constrain global crude flows in the near term.
The Energy Information Administration reported Wednesday a sharper-than-expected decline in U.S. crude inventories for the week ending Jan. 10, further fueling the market&#8217;s bullish sentiment.
Data showed U.S. crude oil inventories fell by 1.961 million barrels last week, exceeding market expectations of a 1.6 million-barrel draw. 
This marked the eighth consecutive weekly decline, pushing U.S. crude commercial stockpiles — excluding the Strategic Petroleum Reserve — to their lowest levels since April 2022.
<h1 class="wp-block-heading">The Impact Of U.S. Sanctions On Russia, Iran</h1>
On Jan. 10, the Biden administration announced sweeping new sanctions targeting Russia. The measures include restrictions on two major Russian producers, Gazprom Neft and Surgutneftegaz, as well as over 160 tankers carrying oil from Russia, Iran, and Venezuela.
The sanctions also complicate ship insurance arrangements, further disrupting logistics for these nations. 
The International Energy Agency, in its latest Oil Market Report released Wednesday, highlighted the potential ramifications of these sanctions, stating:
"Benchmark crude oil prices rallied in early January as U.S. sanctions on Iran and Russia intensified and freezing temperatures swept across large parts of the Northern Hemisphere."
Speculation is mounting that the incoming U.S. administration under President-elect Donald Trump will adopt an even tougher stance on Iran, potentially exacerbating supply constraints. 
"While it is too early to fully quantify the potential impact from these new measures, some operators have reportedly already started to pull back from Iranian and Russian oil," the IEA said.
Freezing temperatures across major oil-consuming regions in the Northern Hemisphere have further tightened energy markets, boosting demand for heating fuels. This seasonal surge in consumption, combined with shrinking inventories and sanctions-related disruptions, leaves the oil market vulnerable to additional supply shocks.
"If decreases in supply from weather impacts, sanctions, or other developments become substantial, oil stocks can quickly be drawn to meet operational requirements in the near term," the IEA stated.
Earlier this week, Goldman Sachs commodity analyst Daan Struyven warned that in a scenario of combined disruptions in Russian and Iranian oil flows, crude prices could rally up <a href="https://www.benzinga.com/markets/25/01/42965857/oil-could-hit-90-goldman-sachs-says-trump-may-not-ease-sanctions-on-russia">to $90 a barrel.</a> 
Read Now: 
<ul>
<li><a href="https://www.benzinga.com/news/global/25/01/43013312/defense-stocks-fall-on-gaza-ceasefire-while-broader-market-rallies-whats-going-on">Defense Stocks Fall On Gaza Ceasefire While Broader Market Rallies: What&#8217;s Going On?</a></li>
</ul>
Photo: Shutterstock

Macro Economic Events

Specialty ETFs

Commodities

Global

Economics

Markets

ETFs

Oil Prices Break $80, Reach 6-Month Highs Despite Israel-Hamas Ceasefire Deal: Why Is Crude Rallying?

Short-seller Hindenburg Research on Wednesday announced plans to disband the <a href="https://www.benzinga.com/topic/hindenburg-research">New York-based investment firm</a>.
&#8220;The plan has been to wind up after we finished the pipeline of ideas we were working on. And as of the last Ponzi cases we just completed and are sharing with regulators, that day is today,&#8221; Hindenburg founder Nate Anderson said in a blog <a href="https://hindenburgresearch.com/gratitude/">post</a>.
What To Know: Anderson founded Hindenburg Research in 2017. The first half of the letter published on Hindenburg&#8217;s site is a reflection on the success of the company and how it came to be. 
&#8220;Nearly 100 individuals have been charged civilly or criminally by regulators at least in part through our work, including billionaires and oligarchs. We shook some empires that we felt needed shaking,&#8221; Anderson said.
See Also: <a href="https://www.benzinga.com/25/01/43013717/fed-beige-book-flags-moderate-growth-yet-tariffs-immigration-policies-spark-concerns">Fed Beige Book Flags Moderate Growth, Yet Tariffs, Immigration Policies Spark Concerns</a>
About halfway through, Anderson addresses the disbandment, but he said there is no particular reason why. Anderson noted that he felt like he had some things to prove to himself early on, but that he has &#8220;finally found some comfort&#8221; with himself. Anderson also suggested his professional life has taken a toll on his well-being, adding that the &#8220;intensity and focus&#8221; required for the role has come at a cost.
&#8220;Someone once told me that at a certain point a successful career becomes a selfish act,&#8221; he said. 
Anderson said his immediate focus is on finding opportunities for members of the Hindenburg team. Some will be starting their own research firms, while others are seeking different opportunities. 
Anderson also noted he plans to spend the next six months or so working on putting together materials to open-source Hindenburg&#8217;s research model and share how the firm conducted its research so that others may be inspired to do the same.
Hindenburg was the short-selling firm behind some major sell-offs in recent years including <a href="https://www.benzinga.com/short-sellers/23/03/31474945/short-seller-that-sunk-second-richest-man-has-new-target-and-jack-dorsey-is-in-the-crosshairs">Adani Group</a> and Super Micro Computer Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>). Hindenburg has also targeted big names like Icahn Enterprises L.P. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IEP#NASDAQ">IEP</a>), Roblox Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) and most recently, Carvana Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>).
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/01/42769626/hindenburg-shorts-carvana-stock-claims-used-car-retailers-turnaround-is-a-mirage">Hindenburg Shorts Carvana Stock, Claims Used Car Retailer&#8217;s Turnaround Is A &#8216;Mirage&#8217;</a></li>
</ul>
Photo: Courtesy of Hindenburg Research.

Short Sellers

Management

CVNA

RBLX

SMCI

Hindenburg Research Is Closing Up Shop: 'We Shook Some Empires That We Felt Needed Shaking'

In a groundbreaking development, Israel and Hamas have reached a ceasefire agreement Wednesday following prolonged conflict in Gaza, reports The Washington Post. The deal, confirmed by U.S. President Joe Biden, aims to halt the hostilities of the past 15 months and facilitate the release of hostages held by Hamas, marking a significant step toward easing tensions in the region.
The agreement requires ratification by a vote of Israel's cabinet. According to Qatar&#8217;s Prime Minister Mohammed bin Abdulrahman Al Thani, implementation of the agreement is set to start Sunday.
<h1 class="wp-block-heading">Key Details of the Ceasefire Agreement</h1>
<ol>
<li>Hostage Release:
<ul>
<li>Hamas has agreed to release hostages, prioritizing women, children and elderly individuals.</li>
<li>The deal includes mechanisms for monitoring and ensuring the safe return of hostages.</li>
</ul>
</li>
<li>Ceasefire Implementation:
<ul>
<li>The agreement entails an immediate cessation of all military operations by both parties.</li>
<li>Israeli forces will initiate a phased withdrawal from Gaza while maintaining a security buffer.</li>
</ul>
</li>
<li>Humanitarian Aid and Reconstruction:
<ul>
<li>Provisions for increased humanitarian assistance to Gaza, including medical supplies, food and essential infrastructure support.</li>
<li>International agencies are expected to oversee aid distribution to ensure it reaches civilians in need.</li>
</ul>
</li>
<li>Prisoner Exchange:
<ul>
<li>In exchange for the release of hostages, Israel will release several Palestinian detainees, with a focus on minors and women.</li>
</ul>
</li>
</ol>
<h1 class="wp-block-heading">International Mediation</h1>
The ceasefire was achieved through intense diplomatic efforts led by Egypt, Qatar and the U.S. Biden played a pivotal role, maintaining direct communication with both Israeli and Palestinian leaders. Steve Witkoff, President-elect Donald Trump's special envoy to the Middle East, also played an instrumental role, said the Washington Post. 
<h1 class="wp-block-heading">Global Reactions</h1>
<ul>
<li>U.S: Biden lauded the agreement as a &#8220;crucial step toward peace&#8221; and pledged continued U.S. support for humanitarian and diplomatic initiatives.</li>
<li>United Nations: Secretary-General António Guterres called the deal a "moment of hope" and urged all parties to abide by its terms.</li>
<li>Public Sentiment: Families of hostages in Israel expressed cautious optimism, while Gaza residents welcomed the cessation of airstrikes and the promise of aid.</li>
</ul>
<h1 class="wp-block-heading">Challenges Ahead</h1>
Despite the breakthrough, challenges remain in implementing and sustaining the agreement. Analysts warn of potential setbacks due to mistrust between the parties and the volatile nature of the region's politics.
The international community has committed to monitoring the situation closely, with hopes that this ceasefire will pave the way for broader negotiations addressing the underlying causes of the conflict.
Photo: Shutterstock

Israel, Hamas Agree To Ceasefire Deal Including Hostage Release, Biden Confirms

The Companies expect product to be available for order in the U.S. in early February. Niktimvo is approved for the treatment of chronic graft-versus-host disease (GVHD) after failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kg (88.2 lbs).
&nbsp;Niktimvo is the first and only FDA-approved prescription treatment for chronic GVHD that targets CSF-1R to reduce the drivers of inflammation and fibrosis.

INCY

SNDX

Incyte, Syndax Announce FDA Approval Of Niktimvo 9 mg And 22 mg Vial Sizes; US Launch Expected In Early February

W.W. Grainger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWW#NYSE">GWW</a>) has outperformed the market over the past 5 years by 14.39% on an annualized basis producing an average annual return of 26.73%. Currently, W.W. Grainger has a market capitalization of $53.38 billion. 
Buying $1000 In GWW: If an investor had bought $1000 of GWW stock 5 years ago, it would be worth $3,269.13 today based on a price of $1093.36 for GWW at the time of writing.
<h3>W.W. Grainger's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736980217_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning W.W. Grainger Stock In The Last 5 Years

ImmunityBio responding to requests for information from both Agencies and the potential for approval in European Union and United Kingdom by 2026.
 &nbsp;

IBRX

ImmunityBio Reports Submission Of Applications For ANKTIVA + BCG To EMA And MHRA

ImmunityBio Says Preparing To Submit sBLA In 2025 For Its Treatment Targeting Bacillus Calmette-guérin Unresponsive Non-muscle Invasive Bladder Cancer In The Papillary Indication

The Company intends to announce its preliminary estimated fourth quarter and year-end financial results on an ongoing annual basis due to the predictability of its subscription model and having finalized year-end membership levels.&nbsp;

Life Time Group To Report Preliminary Estimated Q4 Financial Results On January 16

Offerings

Redwood Trust Reports Pricing Of Public Offering Of $90M Of Its 9.125% Senior Notes Due 2030

First Citizens BancShares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>) has outperformed the market over the past 10 years by 13.93% on an annualized basis producing an average annual return of 25.29%. Currently, First Citizens BancShares has a market capitalization of $30.11 billion. 
Buying $1000 In FCNCA: If an investor had bought $1000 of FCNCA stock 10 years ago, it would be worth $9,532.86 today based on a price of $2152.52 for FCNCA at the time of writing.
<h3>First Citizens BancShares's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736979313_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FCNCA

Here's How Much $1000 Invested In First Citizens BancShares 10 Years Ago Would Be Worth Today

USAP

Universal Stainless Stockholders Vote At Special Meeting Of Stockholders To Approve Company's Pending Acquisition By Aperam

Synovus Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNV#NYSE">SNV</a>) reported quarterly earnings of $1.25 per share which beat the analyst consensus estimate of $1.15 by 8.7 percent. This is a 56.25 percent increase over earnings of $0.80 per share from the same period last year. The company reported quarterly sales of $580.58 million which beat the analyst consensus estimate of $566.59 million by 2.47 percent. This is a 18.81 percent increase over sales of $488.68 million the same period last year.

Earnings

Earnings Beats

Synovus Finl Q4 2024 Adj EPS $1.25 Beats $1.15 Estimate, Sales $580.58M Beat $566.59M Estimate

Under Nasdaq rules, the Company has 60 calendar days, or until March 8, 2025, to either file the Annual Report or to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rule.

NVNI

Nvni Group Receives Notification Of Non-Compliance From Nasdaq Due To Its Delay In Filing Its Interim Financial Statements

The deal range was $6.00-$6.50. TD Cowen, Cantor Fitzgerald, LifeSci Capital, Oppenheimer and Scotiabank acted as joint book running managers for t...

Protara Therapeutics 13.69M share Spot Secondary priced at $6.25

Protara: Six-Month NMIBC Treatment Data Bodes Well For Mid-2025 Catalyst

Protara Therapeutics: Carving New Roads In Bladder Cancer

An announcement from Protara Therapeutics ( ($TARA) ) is now available. Protara Therapeutics has announced the closing of a public offering of comm...

Protara Therapeutics Raises $100M in Stock Offering

Latest data shows the largest indicative borrow rate increases among liquid option names include: FuelCell (FCEL) 34.51% +1.31, Reviva Pharmaceutic...

Largest borrow rate increases among liquid names

Protara Therapeutics: Rising From The Ashes

Latest data shows the largest indicative borrow rate increases among liquid option names include: VinFast Auto LTD (VFS) 102.59% +3.02, Direxion Oi...

Latest data shows the largest indicative borrow rate increases among liquid option names include: Galectin Therapeutics (GALT) 85.37% +13.41, Red C...

TARA-002 in NMIBC: In December 2024, the Company reported positive interim results from its ongoing Phase 2 open-label ADVANCED-2 trial in in NMIBC...

Protara Therapeutics announces planned 2025 milestones

Protara Therapeutics ( ($TARA) ) has shared an announcement. Protara Therapeutics announced updates and future milestones for 2025, following a rec...

Protara Therapeutics Outlines 2025 Milestones After Fundraising

CMRX

FCEL

GALT

GRRR

LITM

OMER

RCAT

RGTI

RVPH

SNPS

SOXS

UPRO

VRAR

WKHS

Press Releases

Protara Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference

Protara Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update

Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the 25th Annual Meeting of the Society of Urologic Oncology

Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC on Thursday, December 5, 2024

Protara Announces Positive Results from the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC

Financing

Protara Announces Proposed Public Offering

Protara Announces Pricing of $100 Million Public Offering

Protara Announces Closing of $100 Million Public Offering

Protara Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Protara Highlights Recent Updates and Anticipated 2025 Milestones

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

Alector

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Coherus BioSciences

Checkpoint Therapeutics, Inc. - Common Stock

Checkpoint Therapeutics

Cellectis S.A. - American Depositary Shares

Cellectis

Greenwich LifeSciences, Inc. - Common stock

Greenwich LifeSciences

Genfit

Gossamer Bio

TuHURA Biosciences

Inhibikase Therapeutics, Inc. - Common Stock

Inhibikase Therapeutics

Inhibrx Biosciences

Larimar Therapeutics, Inc. - Common Stock

Larimar Therapeutics

Lexeo Therapeutics

Lyell Immunopharma

Macrogenics

Monopar Therapeutics

Molecular Partners AG - American Depositary Shares

Molecular Partners

Nkarta

Protalix BioTherapeutics, Inc. (DE) Common Stock

Protalix BioTherapeutics

ProKidney Corp. - Class A Ordinary Shares

ProKidney

Acelyrin

Vor Biopharma

Vaxart

Zentalis Pharmaceuticals, Inc. - common stock

Zentalis Pharma

Guggenheim

HC Wainwright & Co.

Oppenheimer

매주,&nbsp;벤징가의&nbsp;스톡 위스퍼 지수(Benzinga's Stock Whisper Index)는 독점 데이터(proprietary data)와 패턴 인식의 조합을 사용하여&nbsp;<a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">표면 바로 아래에서 주목</a>을 받을 만한 주식 5종목을 소개한다.



투자자들은 가치가 저평가된, 관심이 적은, 새로운 주식들을 항상 찾고 있다. 소매 거래자들이 사용할 수 있는 방법은 무수히 많기 때문에 새로운 기회를 발견하고 특정 주식이 관심을 가져야 하는 이유를 이해하기 위해 풍부한 정보를 조사하는 것이 어려운 경우가 많다.



다음은 12월 6일 주간 벤징가 ‘스톡 위스퍼' 지수의 개요:



1. 프로타라 테라퓨틱스&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARA#NASDAQ">TARA</a>):



프로타라의 주가는 회사가 ADVANCED-2 시험의 2단계 결과를 보고한 후 <a href="https://www.benzinga.com/24/12/42343355/why-is-protara-therapeutics-stock-skyrocketing-over-100-on-thursday" target="_blank" rel="noreferrer noopener">이번 주에 급등</a>했다. 침습성 방광암을 표적으로 하는 TARA-002에 대한 임상시험은 많은 환자들에게 완전한 반응을 보였다.



회사는 제25차 비뇨기종양학회 연례회의에서 이 결과를 보고했다. 프로타라는 2025년 중반에 임상시험을 위해 12개월간 평가 가능한 환자의 데이터를 보고할 예정이다.



프로타라 테라퓨틱스의 CEO 제시 셰퍼먼(Jesse Shefferman)은 &#8220;우리는 국제적인 사이트 확장과 함께 이러한 고무적인 데이터가 환자 등록을 가속화할 것이라고 믿으며 2025년 중반에 12개월 평가 가능한 환자의 초기 데이터를 보고할 수 있기를 기대한다&#8221;고 말했다.



아래 <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120624&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a> 차트는 한 주 동안 급등한 주가를 보여줍니다. 프로타라 주가는 지난 5일 101.02% 급등했다. 2024년 현재까지 181% 이상 상승했다.



<figure class="wp-block-image"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06101858/Screenshot-260.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" alt=""/></figure>



2. 마라 홀딩&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>):



비트코인(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) 가격이 <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42336184/exclusive-bitcoin-crossing-100000-is-a-defining-moment-experts-say" target="_blank" rel="noreferrer noopener">100,000달러를 넘어 치솟았</a>고 회사 업데이트로 인해 마라 홀딩스는 이번 주 동안 독자들의 큰 관심을 끌 수 있었다. 이 회사는 최근 11월에 907개의 비트코인을 채굴했다고 <a href="https://www.benzinga.com/24/12/42267974/whats-going-on-with-bitcoin-mining-stock-mara-holdings-monday" target="_blank" rel="noreferrer noopener">공유</a>했는데, 이는 전월 대비 26% 증가한 수치이다. 2024년에 회사는 8,563개의 비트코인을 채굴했다.



마라의 CEO 프레드 티엘(Fred Thiel)은 &#8220;11월은 마라에게 기록적인 달이었다. 우리의 채굴 작업은 추가 채굴기의 성공적인 배치와 향상된 운영 효율성에 힘입어 전례 없는 수준의 생산량을 달성했다&#8221;고 말했다.



또한 회사는 기존 전환사채를 구매하고 추가 비트코인을 획득하는 데 사용할 7억 달러의 0% 전환선순위 채권을 제공할 <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42265676/mara-targets-btc-and-debt-buybacks-with-new-700m-convertible-notes-offering-mstrs-michael-saylor-says-it-is-a-company-on-the-bitcoin-standard" target="_blank" rel="noreferrer noopener">계획을 발표</a>했다. 추가 비트코인을 구매하기 위한 컨버터블 노트 전략은 마이크로스트레티지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>)가 해왔던 전략과 유사하다.



마이크로스트레티지의 회장 마이클 세일러는 마라가 &#8220;비트코인 표준을 따르는 회사&#8221;라고 말했다.



11월 30일 현재 마라는 34,959개의 비트코인을 보유하고 있어 상장 기업 중 가장 큰 보유자 중 하나이다.



<figure class="wp-block-image"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06101916/Screenshot-262.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" alt=""/></figure>



3. 더 트레이드 데스크 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>):



로쿠(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>)와의 합병 추측으로 인해 트레이드 데스크 주가가 <a href="https://www.benzinga.com/news/24/12/42342085/why-trade-desk-ttd-stock-is-up-8-this-week" target="_blank" rel="noreferrer noopener">이번 주에 급등</a>했고 벤징가 독자들의 관심을 얻었다.



구겐하임의 분석가들은 트레이드 데스크의 광고 플랫폼과 로쿠의 스트리밍 공간을 결합하고 연결된 TV 공간에서 거대 기업을 만들 두 회사 간의 합병 사례를 제시했다. 구겐하임의 분석가들은 합병으로 인한 이익이 위험보다 더 클 것이며 합병된 회사는 아마존이나 알파벳과 같은 회사에 비해 더 나은 경쟁자가 될 것이라고 말했다.



합병 추측은 트레이드 데스크가 스마트 TV 제조업체와 협력하여 배포할 계획인 벤츄라(Ventura) <a href="https://www.benzinga.com/24/11/42097269/the-trade-desk-launches-ventura-transforming-streaming-tv-advertising" target="_blank" rel="noreferrer noopener">스트리밍 운영 체제</a>를 공개한 지 한 달도 채 되지 않아 나온 것이다. 벤츄라는 이르면 2025년 출시될 예정이다.



트레이드 데스크에서는 최근 스코샤 은행이 부문별 아웃퍼폼(Outperform) 등급과 133달러 목표 가격으로 커버리지를 시작한 것을 포함하여 <a href="https://www.benzinga.com/quote/TTD/analyst-ratings" target="_blank" rel="noreferrer noopener">여러 분석가의 메모</a>를 확인했다. 맥쿼리는 아웃퍼폼 투자의견을 유지하고 목표주가를 133달러에서 150달러로 상향 조정했다. 에버코어 ISI는 아웃퍼폼 등급을 유지하고 목표 가격을 110달러에서 135달러로 높였다.



<figure class="wp-block-image"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06101932/Screenshot-264.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" alt=""/></figure>



4. 사운드하운드 AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>):



인공지능(AI) 관련 회사는 이번 주 동안 독자들의 관심이 높아졌으며, 올해 들어 주식 621% 이상 급등했다.



회사가 추가 레스토랑에 음성 AI 스마트 주문 시스템을 <a href="https://www.benzinga.com/24/12/42348247/soundhound-ai-shares-were-on-the-rise-today-whats-going-on" target="_blank" rel="noreferrer noopener">배포한다고 발표</a>한 후 주가가 상승했다. 회사의 AI 기반 레스토랑 솔루션은 전화, 키오스크, 드라이브스루 및 헤드셋 주문 시스템을 지원하는 기술을 통해 전 세계 10,000개 이상의 위치에서 사용되고 있다. 이 회사는 또한 최근 아멜리아(Amelia 대화형) AI 에이전트가 2024년에 100,000건 이상의 고객 통화를 처리하여 고객의 운영 효율성을 지원했다고 밝혔다.



사운드하운드 주가는 2024년에도 계속해서 높게 거래되고 있으며, 회사가 11월 3분기 재무 보고서를 보고한 직후에 나온 주에 60% 이상 상승했다. 회사는 2024년과 2025년 모두 연간 수익 전망을 높였으며 앞으로 투자자들은 주식을 면밀히 모니터링할 것이다.



<figure class="wp-block-image"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06101949/Screenshot-265.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" alt=""/></figure>



5. 오라클클 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>):



투자자들의 큰 관심을 받고 있는 또 다른 주식은 회사의 2분기 재무 결과를 앞둔 오라클이다.



오라클은 월요일 시장 마감 후 2분기 실적을 발표할 예정이다. 분석가들은 이 회사가 지난해 2분기 1.34달러에서 증가한 1.48달러의 주당 순이익을 보고할 것으로 예상하고 있다. 회사는 8분기 연속 주당순이익이 분석가 추정치를 상회했다. 분석가들은 회사가 지난해 2분기의 129억 달러보다 증가한 141억 달러의 분기 매출을 보고할 것으로 예상하고 있다.



회사는 최근 주당 이익에 있어 일련의 좋은 결과를 얻었지만 수익 예측을 깨는 데 어려움을 겪었다. 회사는 지난 10개 분기 중 단 4개 분기에서만 분석가의 예상 매출을 넘어섰다.



웨드부시의 분석가 댄 아이브스는 <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42307179/salesforce-palantir-and-oracle-spearhead-an-ai-revolution-says-wedbushs-dan-ives-a-renaissance-of-growth" target="_blank" rel="noreferrer noopener">최근</a> 오라클이 2025년에 &#8216;AI 혁명&#8217;의 혜택을 누릴 것이라고 말했다. 분석가들은 분기별 재무 결과를 앞두고 오라클 주식에 대한 <a href="https://www.benzinga.com/quote/ORCL/analyst-ratings" target="_blank" rel="noreferrer noopener">목표 가격을 높여</a>&nbsp;왔다.



<figure class="wp-block-image"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06102005/Screenshot-266.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" alt=""/></figure>



다음 주 보고서를 계속 지켜봐 주시기 바랍니다.&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent111524&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">여기에서</a>&nbsp;Benzinga Pro를 팔로우하여 모든 최신 헤드라인과 시장을 움직이는 주요 기사를 확인하세요.



여기에서 최근 ‘스톡 위스퍼 지수' 보고서를 읽어보세요.



<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EB%B2%A4%EC%A7%95%EA%B0%80%EC%9D%98-%EC%8A%A4%ED%86%A1-%EC%9C%84%EC%8A%A4%ED%8D%BC-%EC%A7%80%EC%88%98-%EC%82%AC%EC%9D%B4%EB%A8%BC-%ED%94%84%EB%A1%9C%ED%8D%BC%ED%8B%B0-%EC%95%A8%EB%A6%AC/" target="_blank" rel="noreferrer noopener">11월 30일</a></li>



<li><a href="https://kr.benzinga.com/news/usa/stocks/%EB%B2%A4%EC%A7%95%EA%B0%80%EC%9D%98-%EC%8A%A4%ED%86%A1-%EC%9C%84%EC%8A%A4%ED%8D%BC-%EC%A7%80%EC%88%98-%EB%8D%B8%ED%83%80-%ED%95%AD%EA%B3%B5-%EB%82%98%EC%9D%B4%ED%82%A4-%EC%98%A4%ED%86%A0/" target="_blank" rel="noreferrer noopener">11월 23일</a></li>



<li><a href="https://kr.benzinga.com/news/usa/stocks/%EB%B2%A4%EC%A7%95%EA%B0%80%EC%9D%98-%EC%8A%A4%ED%86%A1-%EC%9C%84%EC%8A%A4%ED%8D%BC-%EC%A7%80%EC%88%98-%EC%95%A1%EC%86%90-%EC%8A%A4%EB%85%B8%EC%9A%B0%ED%94%8C%EB%A0%88%EC%9D%B4-%EC%97%A0/" target="_blank" rel="noreferrer noopener">11월 16일</a></li>



<li><a href="https://kr.benzinga.com/news/usa/stocks/%EB%B2%A4%EC%A7%95%EA%B0%80%EC%9D%98-%EC%8A%A4%ED%86%A1-%EC%9C%84%EC%8A%A4%ED%8D%BC-%EC%A7%80%EC%88%98-%EC%9D%B8%EC%8A%A4%EB%A9%94%EB%93%9C-%EC%9D%B8%ED%8A%9C%EC%9D%B4%ED%8B%B0%EB%B8%8C/" target="_blank" rel="noreferrer noopener">11월 9일</a></li>



<li><a href="https://kr.benzinga.com/news/usa/stocks/%EB%B2%A4%EC%A7%95%EA%B0%80%EC%9D%98-%EC%8A%A4%ED%86%A1-%EC%9C%84%EC%8A%A4%ED%8D%BC-%EC%A7%80%EC%88%98-%EC%95%A0%EC%A7%88%EB%9F%B0%ED%8A%B8-%ED%8A%B8%EB%A0%88%EC%9D%B4%EB%93%9C/" target="_blank" rel="noreferrer noopener">11월 2일</a></li>
</ul>



다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다.&nbsp;<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

벤징가의 '스톡 위스퍼' 지수: 프로타라, 마라, 트레이드 데스크, 사운드하운드 AI 및 오라클

매주, 벤징가의 스톡 위스퍼 지수(Benzinga's Stock Whisper Index)는 독점 데이터(proprietary data)와 패턴 인식의 조합을 사용하여 <a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">표면 바로 아래에서 주목</a>을 받을 만한 주식 5종목을 소개한다.
투자자들은 가치가 저평가된, 관심이 적은, 새로운 주식들을 항상 찾고 있다. 소매 거래자들이 사용할 수 있는 방법은 무수히 많기 때문에 새로운 기회를 발견하고 특정 주식이 관심을 가져야 하는 이유를 이해하기 위해 풍부한 정보를 조사하는 것이 어려운 경우가 많다.
다음은 12월 6일 주간 벤징가 ‘스톡 위스퍼' 지수의 개요:
1. 프로타라 테라퓨틱스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARA#NASDAQ">TARA</a>):
프로타라의 주가는 회사가 ADVANCED-2 시험의 2단계 결과를 보고한 후 <a href="https://www.benzinga.com/24/12/42343355/why-is-protara-therapeutics-stock-skyrocketing-over-100-on-thursday" target="_blank" rel="noopener">이번 주에 급등</a>했다. 침습성 방광암을 표적으로 하는 TARA-002에 대한 임상시험은 많은 환자들에게 완전한 반응을 보였다.
회사는 제25차 비뇨기종양학회 연례회의에서 이 결과를 보고했다. 프로타라는 2025년 중반에 임상시험을 위해 12개월간 평가 가능한 환자의 데이터를 보고할 예정이다.
프로타라 테라퓨틱스의 CEO 제시 셰퍼먼(Jesse Shefferman)은 &#8220;우리는 국제적인 사이트 확장과 함께 이러한 고무적인 데이터가 환자 등록을 가속화할 것이라고 믿으며 2025년 중반에 12개월 평가 가능한 환자의 초기 데이터를 보고할 수 있기를 기대한다&#8221;고 말했다.
아래 <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120624&amp;t=be2bearmibe3na1" target="_blank" rel="noopener">Benzinga Pro</a> 차트는 한 주 동안 급등한 주가를 보여줍니다. 프로타라 주가는 지난 5일 101.02% 급등했다. 2024년 현재까지 181% 이상 상승했다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06101858/Screenshot-260.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
2. 마라 홀딩 (NASDAQ:<a class="ticker" style="font-size: revert;" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>):
비트코인(CRYPTO:<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/btc-usd" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for BTC/USD">BTC</a>) 가격이 <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42336184/exclusive-bitcoin-crossing-100000-is-a-defining-moment-experts-say" target="_blank" rel="noopener">100,000달러를 넘어 치솟았</a>고 회사 업데이트로 인해 마라 홀딩스는 이번 주 동안 독자들의 큰 관심을 끌 수 있었다. 이 회사는 최근 11월에 907개의 비트코인을 채굴했다고 <a href="https://www.benzinga.com/24/12/42267974/whats-going-on-with-bitcoin-mining-stock-mara-holdings-monday" target="_blank" rel="noopener">공유</a>했는데, 이는 전월 대비 26% 증가한 수치이다. 2024년에 회사는 8,563개의 비트코인을 채굴했다.
마라의 CEO 프레드 티엘(Fred Thiel)은 &#8220;11월은 마라에게 기록적인 달이었다. 우리의 채굴 작업은 추가 채굴기의 성공적인 배치와 향상된 운영 효율성에 힘입어 전례 없는 수준의 생산량을 달성했다&#8221;고 말했다.
또한 회사는 기존 전환사채를 구매하고 추가 비트코인을 획득하는 데 사용할 7억 달러의 0% 전환선순위 채권을 제공할 <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42265676/mara-targets-btc-and-debt-buybacks-with-new-700m-convertible-notes-offering-mstrs-michael-saylor-says-it-is-a-company-on-the-bitcoin-standard" target="_blank" rel="noopener">계획을 발표</a>했다. 추가 비트코인을 구매하기 위한 컨버터블 노트 전략은 마이크로스트레티지(NASDAQ:<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/mstr" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for MSTR">MSTR</a>)가 해왔던 전략과 유사하다.
마이크로스트레티지의 회장 마이클 세일러는 마라가 &#8220;비트코인 표준을 따르는 회사&#8221;라고 말했다.
11월 30일 현재 마라는 34,959개의 비트코인을 보유하고 있어 상장 기업 중 가장 큰 보유자 중 하나이다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06101916/Screenshot-262.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
3. 더 트레이드 데스크 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>):
로쿠(NASDAQ:<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/roku" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for ROKU">ROKU</a>)와의 합병 추측으로 인해 트레이드 데스크 주가가 <a href="https://www.benzinga.com/news/24/12/42342085/why-trade-desk-ttd-stock-is-up-8-this-week" target="_blank" rel="noopener">이번 주에 급등</a>했고 벤징가 독자들의 관심을 얻었다.
구겐하임의 분석가들은 트레이드 데스크의 광고 플랫폼과 로쿠의 스트리밍 공간을 결합하고 연결된 TV 공간에서 거대 기업을 만들 두 회사 간의 합병 사례를 제시했다. 구겐하임의 분석가들은 합병으로 인한 이익이 위험보다 더 클 것이며 합병된 회사는 아마존이나 알파벳과 같은 회사에 비해 더 나은 경쟁자가 될 것이라고 말했다.
합병 추측은 트레이드 데스크가 스마트 TV 제조업체와 협력하여 배포할 계획인 벤츄라(Ventura) <a href="https://www.benzinga.com/24/11/42097269/the-trade-desk-launches-ventura-transforming-streaming-tv-advertising" target="_blank" rel="noopener">스트리밍 운영 체제</a>를 공개한 지 한 달도 채 되지 않아 나온 것이다. 벤츄라는 이르면 2025년 출시될 예정이다.
트레이드 데스크에서는 최근 스코샤 은행이 부문별 아웃퍼폼(Outperform) 등급과 133달러 목표 가격으로 커버리지를 시작한 것을 포함하여 <a href="https://www.benzinga.com/quote/TTD/analyst-ratings" target="_blank" rel="noopener">여러 분석가의 메모</a>를 확인했다. 맥쿼리는 아웃퍼폼 투자의견을 유지하고 목표주가를 133달러에서 150달러로 상향 조정했다. 에버코어 ISI는 아웃퍼폼 등급을 유지하고 목표 가격을 110달러에서 135달러로 높였다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06101932/Screenshot-264.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
4. 사운드하운드 AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>):
인공지능(AI) 관련 회사는 이번 주 동안 독자들의 관심이 높아졌으며, 올해 들어 주식 621% 이상 급등했다.
회사가 추가 레스토랑에 음성 AI 스마트 주문 시스템을 <a href="https://www.benzinga.com/24/12/42348247/soundhound-ai-shares-were-on-the-rise-today-whats-going-on" target="_blank" rel="noopener">배포한다고 발표</a>한 후 주가가 상승했다. 회사의 AI 기반 레스토랑 솔루션은 전화, 키오스크, 드라이브스루 및 헤드셋 주문 시스템을 지원하는 기술을 통해 전 세계 10,000개 이상의 위치에서 사용되고 있다. 이 회사는 또한 최근 아멜리아(Amelia 대화형) AI 에이전트가 2024년에 100,000건 이상의 고객 통화를 처리하여 고객의 운영 효율성을 지원했다고 밝혔다.
사운드하운드 주가는 2024년에도 계속해서 높게 거래되고 있으며, 회사가 11월 3분기 재무 보고서를 보고한 직후에 나온 주에 60% 이상 상승했다. 회사는 2024년과 2025년 모두 연간 수익 전망을 높였으며 앞으로 투자자들은 주식을 면밀히 모니터링할 것이다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06101949/Screenshot-265.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
5. 오라클클 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>):
투자자들의 큰 관심을 받고 있는 또 다른 주식은 회사의 2분기 재무 결과를 앞둔 오라클이다.
오라클은 월요일 시장 마감 후 2분기 실적을 발표할 예정이다. 분석가들은 이 회사가 지난해 2분기 1.34달러에서 증가한 1.48달러의 주당 순이익을 보고할 것으로 예상하고 있다. 회사는 8분기 연속 주당순이익이 분석가 추정치를 상회했다. 분석가들은 회사가 지난해 2분기의 129억 달러보다 증가한 141억 달러의 분기 매출을 보고할 것으로 예상하고 있다.
회사는 최근 주당 이익에 있어 일련의 좋은 결과를 얻었지만 수익 예측을 깨는 데 어려움을 겪었다. 회사는 지난 10개 분기 중 단 4개 분기에서만 분석가의 예상 매출을 넘어섰다.
웨드부시의 분석가 댄 아이브스는 <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42307179/salesforce-palantir-and-oracle-spearhead-an-ai-revolution-says-wedbushs-dan-ives-a-renaissance-of-growth" target="_blank" rel="noopener">최근</a> 오라클이 2025년에 &#8216;AI 혁명&#8217;의 혜택을 누릴 것이라고 말했다. 분석가들은 분기별 재무 결과를 앞두고 오라클 주식에 대한 <a href="https://www.benzinga.com/quote/ORCL/analyst-ratings" target="_blank" rel="noopener">목표 가격을 높여</a> 왔다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06102005/Screenshot-266.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
다음 주 보고서를 계속 지켜봐 주시기 바랍니다. <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent111524&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">여기에서</a> Benzinga Pro를 팔로우하여 모든 최신 헤드라인과 시장을 움직이는 주요 기사를 확인하세요.
여기에서 최근 ‘스톡 위스퍼 지수' 보고서를 읽어보세요.
<ul class="block core-block">
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EB%B2%A4%EC%A7%95%EA%B0%80%EC%9D%98-%EC%8A%A4%ED%86%A1-%EC%9C%84%EC%8A%A4%ED%8D%BC-%EC%A7%80%EC%88%98-%EC%82%AC%EC%9D%B4%EB%A8%BC-%ED%94%84%EB%A1%9C%ED%8D%BC%ED%8B%B0-%EC%95%A8%EB%A6%AC/" target="_blank" rel="noopener">11월 30일</a></li>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EB%B2%A4%EC%A7%95%EA%B0%80%EC%9D%98-%EC%8A%A4%ED%86%A1-%EC%9C%84%EC%8A%A4%ED%8D%BC-%EC%A7%80%EC%88%98-%EB%8D%B8%ED%83%80-%ED%95%AD%EA%B3%B5-%EB%82%98%EC%9D%B4%ED%82%A4-%EC%98%A4%ED%86%A0/" target="_blank" rel="noopener">11월 23일</a></li>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EB%B2%A4%EC%A7%95%EA%B0%80%EC%9D%98-%EC%8A%A4%ED%86%A1-%EC%9C%84%EC%8A%A4%ED%8D%BC-%EC%A7%80%EC%88%98-%EC%95%A1%EC%86%90-%EC%8A%A4%EB%85%B8%EC%9A%B0%ED%94%8C%EB%A0%88%EC%9D%B4-%EC%97%A0/" target="_blank" rel="noopener">11월 16일</a></li>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EB%B2%A4%EC%A7%95%EA%B0%80%EC%9D%98-%EC%8A%A4%ED%86%A1-%EC%9C%84%EC%8A%A4%ED%8D%BC-%EC%A7%80%EC%88%98-%EC%9D%B8%EC%8A%A4%EB%A9%94%EB%93%9C-%EC%9D%B8%ED%8A%9C%EC%9D%B4%ED%8B%B0%EB%B8%8C/" target="_blank" rel="noopener">11월 9일</a></li>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EB%B2%A4%EC%A7%95%EA%B0%80%EC%9D%98-%EC%8A%A4%ED%86%A1-%EC%9C%84%EC%8A%A4%ED%8D%BC-%EC%A7%80%EC%88%98-%EC%95%A0%EC%A7%88%EB%9F%B0%ED%8A%B8-%ED%8A%B8%EB%A0%88%EC%9D%B4%EB%93%9C/" target="_blank" rel="noopener">11월 2일</a></li>
</ul>
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Protara Therapeutics

뉴스

에 대한 최신 뉴스 Protara Therapeutics (NASDAQ:TARA) 주식

토요일, 12월 07, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌